Descriptor in English: | Apazone |
Descriptor in Spanish: | Apazona |
Descriptor in Portuguese: | Apazona |
Descriptor in French: | Azapropazone |
Entry term(s): |
5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione Apazone Dihydrate Azapropazone Dihydrate, Apazone Prolixan Rheumox Tolyprin |
Tree number(s): |
D03.383.931.190 |
Scope note: | An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout. |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
History Note: | 91(75); was see under TRIAZINES 1975-90 |
DeCS UI: | 27950 |
Descriptor UI: | D001032 |
Date Established: | 1991/01/01 |
Date of Entry: | 1974/11/19 |
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Apazone
- Preferred
Prolixan
- Narrower
Tolyprin
- Narrower
Apazone Dihydrate
- Narrower
Rheumox
- Narrower
Concept UI |
M0001566 |
Scope note | An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout. |
Preferred term | Apazone |
Entry term(s) |
5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione Azapropazone |
Concept UI |
M0001567 |
Preferred term | Prolixan |
Concept UI |
M0440885 |
Preferred term | Tolyprin |
Concept UI |
M0330783 |
Preferred term | Apazone Dihydrate |
Entry term(s) |
Dihydrate, Apazone |
Concept UI |
M0440884 |
Preferred term | Rheumox |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey